C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2002
12/18/2002	CN1386120A 萘酚衍生物 Naphthol derivative
12/18/2002	CN1096265C Preparation of pharmaceutical composition containing novel thiazolidone and oxazolidone
12/17/2002	US6495692 Helium-neon excitable reticulocyte dyes derivable from halolepidines
12/17/2002	US6495691 Their pharmaceutically acceptable salts, wherein the meaning of x is hydrogen, carboxyl, alkoxycarbonyl, aryloxycarbonyl, nitrile, or carbamoyl of the formula ticlopidine, is an antithrombotic drug with platelet aggregation inhibiting
12/17/2002	US6495582 Erk (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
12/17/2002	US6495581 Drug for treating diabetes mellitus, hyperlipemia, impaired glucose tolerance, arterial sclerosis and improving insulin resistance, inflammatory disease
12/17/2002	US6495578 Sulfonamide derivatives having oxadiazole rings
12/17/2002	US6495565 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition
12/17/2002	US6495551 Substituted phenyloxazolidinones and their use as antibiotics
12/17/2002	US6495549 1-heteroaryl-piperidine derivatives; moderating neuronal degeneration; promoting neuronal regeneration and outgrowth; treatog neurological disorders arising from neurodegenerative diseases or other disorders involving nerve damage
12/17/2002	US6495545 1,4-benzodiazepinone derivatives and their use as integrin antagonists
12/17/2002	US6495542 Such as 2-methoxy-n-(2-methyl-1h-benzimidazol-4-yl)-4-(2,3,4,5-tetrahydro-5-oxo-1h-1-benzazepin-1-yl)carbonyl-benzam ide; hypertension, heart failure, renal insufficiency, edema, ascites, vasopressin parasecretion syndrome
12/13/2002	WO2001096332A1 Process for the preparation of a piperazine derivative
12/13/2002	CA2412873A1 Process for the preparation of a piperazine derivative
12/12/2002	WO2002099097A1 Novel compounds for chemiluminescense procedures
12/12/2002	WO2002098856A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
12/12/2002	WO2002098854A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002	WO2002098852A2 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002	WO2002098850A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	WO2002098426A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases
12/12/2002	WO2002098424A1 Novel anti-infectives
12/12/2002	WO2002076977A3 Rho-kinase inhibitors
12/12/2002	WO2002076976A3 Rho-kinase inhibitors
12/12/2002	WO2002069946A3 Use of triazole compounds for prophylaxis and in therapy for neurodegenerative illnesses, brain traumas and cerebral ischaemia
12/12/2002	US20020188133 Producing an isoxazolidinedione compound from beta - methyl L-aspartate via an important intermediate oxazolylethanol derivative
12/12/2002	US20020188131 Sulphonylbenzazolones
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002	US20020188043 Photochromic diarylethene substituted with isoxazole group
12/12/2002	US20020187982 Glucagon antagonists/inverse agonists
12/12/2002	US20020187979 3-heterocyclylpropanohydroxamic acid PCP inhibitors
12/12/2002	DE10125961A1 Carbazolderivate und deren Verwendung zur Herstellung einer Arzneimittelzusammensetzung zur Behandlung von im Zusammenhang mit NPY stehenden Leiden Carbazole derivatives and their use for the preparation of a pharmaceutical composition for the treatment of related ailments associated with NPY
12/12/2002	CA2449813A1 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002	CA2449771A1 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002	CA2449770A1 Novel anti-infectives
12/12/2002	CA2448824A1 Novel compounds for chemiluminescense procedures
12/12/2002	CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263745A1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263727A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/11/2002	EP1263720A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
12/11/2002	EP1095025B1 Benzimidazoles, production thereof and use thereof as medicaments
12/11/2002	EP1023072B1 Analgesic compositions comprising a cholecystokinin and an opioid
12/11/2002	EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors
12/11/2002	EP0937064B1 Substituted oximes derivatives useful as neurokinin antagonists
12/11/2002	EP0937060B1 Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
12/11/2002	EP0805796B1 Cell adhesion inhibitors
12/11/2002	CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
12/11/2002	CN1384824A Process for preparation of oxazole derivatives
12/11/2002	CN1384100A Benzo-1,3-dioxole and benzofuran substituted pentazane derivative
12/11/2002	CN1095839C 4,5-diaryl oxazole derivatives
12/11/2002	CN1095838C 4-cyclohexyl phenyl-oxazolines and their use for controlling animal pests
12/11/2002	CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative
12/10/2002	US6492555 Reaction of a carbamate with either a (s)-secondary alcohol or (s)-epoxide or (s)-ester; bactericides
12/10/2002	US6492406 Pharmaceutically active compounds
12/10/2002	US6492403 Methods of treating C1s-mediated diseases and conditions and compositions thereof
12/10/2002	US6492402 Anticoagulants; peptide derivatives having high antithrombotic activity and oral bioavailability
12/10/2002	US6492401 Sodium hydrogen exchanger type 1 inhibitors; reducing perioperative myocardial tissue damage
12/10/2002	US6492400 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/10/2002	US6492396 Substituted thioacetamides
12/10/2002	US6492393 Compounds useful as anti-inflammatory agents
12/10/2002	US6492390 Treating cyclooxygenase-2 mediated disorders.
12/10/2002	US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002	US6492368 Benzamidine derivatives as factor XA inhibitors
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002	US6492360 Phthalazine derivatives phosphodiesterase 4 inhibitors
12/10/2002	CA2230445C Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
12/05/2002	WO2002096904A1 Novel heterocyclic derivatives and medicinal use thereof
12/05/2002	WO2002096902A1 Carbazole derivatives and their use for the preparation of pharmaceutical compositions for the treatment of npy related diseases
12/05/2002	WO2002096890A2 Regioselective mitsunobu reaction, particularly for preparing bactericidal oxazolidinones
12/05/2002	WO2002096888A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002	WO2002096880A1 Novel heterocyclic compound and medicinal use thereof
12/05/2002	WO2002096876A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002	WO2002096421A1 5-substituted-2-arylpyridines as crf1 modulators
12/05/2002	WO2002096362A2 Method for treating fibrotic diseases or other indications vi
12/05/2002	WO2002096361A2 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
12/05/2002	WO2002096359A2 Piperazine pentanamide hiv protease inhibitors
12/05/2002	WO2002096358A2 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
12/05/2002	WO2002096357A2 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
12/05/2002	WO2002096317A2 Method for treating glaucoma vi
12/05/2002	WO2002074036A3 Substituted benzopyranones as telomerase inhibitors
12/05/2002	WO2002059116A3 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
12/05/2002	WO2002051819A3 Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
12/05/2002	WO2001093840A2 Ligands of integrin receptors
12/05/2002	US20020183524 Preparations and use of an Ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
12/05/2002	US20020183371 Oxazolidinone combinatorial libraries, compositions and methods of preparation
12/05/2002	US20020183334 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder
12/05/2002	US20020183325 Phthalazinone derivatives
12/05/2002	US20020183324 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
12/05/2002	US20020183323 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
12/05/2002	US20020183318 Novel derivatives of flavones, xanthones and coumarins
12/05/2002	US20020183316 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
12/05/2002	US20020183315 Amino-substituted compounds useful as inhibitors of impdh enzyme
12/05/2002	US20020183309 For therapy of acute myocardial infarction, asthma, bipolar disorder, cognitive enhancement, cognitive deficits in psychiatric disorders, cutaneous carcinoma, drug abuse, depression, gastrointestinal disorders, inflammation
12/05/2002	DE10126434A1 New tricyclic thiochromenone derivatives as metabotropic glutamate receptor-1 (mGluR1) antagonists useful for treating e.g. hemorrhagic stroke and atherosclerosis, especially pain or neurodegenerative diseases
12/05/2002	CA2449160A1 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
12/05/2002	CA2449118A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002	CA2449006A1 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method

1 ... 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 ... 647